Results in the elderly with locally advanced rectal cancer from the ACCOR12/PRODIGE 2 phase III trial: Tolerance and efficacy-Reference-Cited by-同舟云学术

Results in the elderly with locally advanced rectal cancer from the ACCOR12/PRODIGE 2 phase III trial: Tolerance and efficacy

Published:2014-01 Issue:1 Volume:110 Page:144-149
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

François Eric,Azria David,Gourgou-Bourgade Sophie,Jarlier Marta,Martel-Laffay Isabelle,Hennequin Christophe,Etienne Pierre-Luc,Vendrely Véronique,Seitz Jean-François,Conroy Thierry,Juzyna Beata,Gerard Jean-Pierre

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference15 articles.

1. Controversies of total mesorectal excision for rectal cancer in elderly patients;Rutten;Lancet Oncol,2008

2. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: Results of FFCD 9203;Gerard;J Clin Oncol,2006

3. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2;Gerard;J Clin Oncol,2010

4. Pathological features of rectal cancer after preoperative radiochemotherapy;Dworak;Int J Colorectal Dis,1997

5. Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older;Margalit;Int J Radiat Oncol Biol Phys,2011

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preoperative chemoradiotherapy in older patients with rectal cancer guided by comprehensive geriatric assessment within a multidisciplinary team—a multicenter phase II trial;BMC Geriatrics;2024-05-21

2. Short course radiotherapy versus radiochemotherapy for locally advanced rectal cancers in the elderly (UNICANCER PRODIGE 42/GERICO 12 study): Quality of life and comprehensive geriatric assessment;Radiotherapy and Oncology;2024-04

3. Preoperative Chemoradiotherapy in Older Patients with Rectal Cancer Guided by Comprehensive Geriatric Assessment within a Multidisciplinary Team—A Multicenter Phase II Trial;2023-06-26

4. Propensity‐score matched analysis of the pathologic outcomes and survival benefits of neoadjuvant therapy in stage II–III anal adenocarcinoma;Journal of Surgical Oncology;2023-05-14

5. Comparison of short course radiotherapy with chemoradiotherapy for locally advanced rectal cancers in the elderly: A multicentre, randomised, non-blinded, phase 3 trial;European Journal of Cancer;2023-02